Innovative solutions to the greatest challenges in pharmaceutical development

15th – 17th March 2021 | Berlin

Thank you to everyone who attended the 11th Global Drug Delivery & Formulation Summit! Key themes for the Summit included:

  • New modalities research opportunities and challenges
  • Personalised therapies, mRNA, Cell and gene therapies
  • Analytical techniques for biotherapeutics
  • 3D printing, flexible manufacturing techniques, continuous manufacturing
  • Multivariate analysis techniques, production process optimisation, digitalisation of
  • pharmaceutical development
  • mAb and bispecific formulation development
  • Oral delivery of biologics and other routes
  • Device development, microneedles, connected devices
  • Integrating human factors into device development, behavioural design

2021 Speakers

Carolin Auch

Merck

Principal Scientist | Lab Head Drug Delivery & Innovation

Dr. Fatima Bennai-Sanfourche

Bayer

Director Medical device Safety, Medical Device Safety Officer

Erwan Bourles

GSK

Senior Manager, Head of Drying and Related Modelling Technologies Drug Product development Unit

Olivier Brass

Sanofi

Senior scientist, lead of research unit, research department

Matthew Clemente

Novo Nordisk

Vice President, Device Development, Device R&D

Gabriele Sadowski

TU Dortmond

Professor for Thermodynamics

Robert Hennig

Merck

Associate Director Drug Delivery & Innovation, Healthcare R&D

Karsten Fluegel

Merck

Postdoctoral Researcher | Drug Delivery & Innovation

Naila El Kechai

Sanofi

Formulation and Drug Product Team Leader

Claus-Michael Lehr

Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)

Head, Dept. of Drug Delivery (DDEL)

Kenneth J. Mandell

LayerBio

Founder and CEO

Dr Ana L Gomes dos Santos

AstraZeneca

Principal Scientist

Ijeoma F. Uchegbu

University College London

Chair in Pharmaceutical Nanoscience

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

Latest News

Upperton Invest £500K in their Tablet Formulation and Manufacturing Capabilities

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) have invested £500K in significantly expanding their tablet manufacturing capabilities with the addition of tablet processing equipment for wet granulation, roller compaction, tablet compression, hardness testing, dedusting, weight sorting and tablet coating throughout 2019 and 2020. This investment of £500K will enhance the company’s development and manufacturing capabilities whilst strengthening their ability to support clients’ research, development and clinical manufacturing needs.

Partner profile: Crux Product Design

With the experience of delivering product innovations in the medical, consumer and performance goods sectors, we have the expertise to adapt and apply our methods to each client’s specific project needs.

Updates from Sensile Medical

Our partner Sensile Medical have an update on two of its major projects: The recent market launch of their first micropump, an infusion pump for Parkinson's disease patients; and their latest project with SQ Innovation for a 3mL furosemide patch pump. they have sent us 3 documents to present to our followers and audience